Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Journalism in pandemic: online training for thousands of international journalists

When I taught media ethics in the University of Minnesota School of Journalism and Mass Communication, I’d be thrilled to teach in an auditorium filled with 150 students. This week, I spoke to an online course that has more than 7,000 international journalists enrolled from more than 150 countries. That’s what I’ve been told by […]


Warning: early vaccine trial results don’t always stand test of time

“The drugmaker Moderna said on Monday that the first coronavirus vaccine to be tested in people appeared to be safe and able to stimulate an immune response against the virus.” That’s what an early New York Times story reported yesterday. Erick Turner, MD, reacted on Twitter: Hey, didn’t you hear? The vaccine “appears to be […]


Flubs and flaws in New York Times stories on llamas and coffee

I’ve written it and said it before: I applaud most of the New York Times pandemic-era news coverage. But I continue to see head-scratching lapses in editorial approach and judgment – flaws that could be so easily corrected with a bit more caution and care. Hoping llamas will become coronavirus heroes is a Times story […]


Mutant coronavirus story upsets scientists about preprint journalism

This is the way many of my days begin these days, being blasted out of my chair by smart skepticism and criticism on coronavirus issues on social media.  Today’s lift-off came from a virology researcher at Cornell: This LATimes article is INFURIATING. So much misinformation based on just that preprint. They took quotes from the […]


Thanks for missing, but it’s still here

I am touched, and I chuckle, when an occasional follower on Twitter writes, “Oh, how I miss!” Or I’ll read, “We need now more than ever.” The fact is that these readers are usually reacting to something just published on, which is still alive. I think I know, though, what followers mean […]


The start of a study is often not newsworthy – even when you bring God into it

On the day a study begins, there isn’t much you can say about it. There is no evidence. There is a hypothesis. You could talk about the protocol – how the study will be done. You can’t jump to any conclusions. This article questions why news organizations report on the first day of a study. […]


What the public didn’t hear about the NIH remdesivir trial

This will not be an article that questions the medical evidence being discussed.  It will focus solely on how the message was communicated to a global audience. I believe that when the results of the NIH-sponsored remdesivir trial – Adaptive COVID-19 Treatment Trial (ACTT), sponsored by the National Institute of Allergy and Infectious Diseases – are […]


The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir

This morning, STAT News reported: The story begins:  A government-run study of Gilead’s remdesivir, perhaps the most closely watched experimental drug to treat the novel coronavirus, showed that the medicine is effective against Covid-19, the disease caused by the virus. Gilead made the announcement in a statement Wednesday, stating: “We understand that the trial has […]


Shining a light on super-spreaders of coronavirus misinformation

NewsGuard calls itself “The Internet Trust Tool.”  And there may have never been a better time to help consumers learn whom to trust than the COVID-19 pandemic era. (You can read more about NewsGuard’s operating model on their site, or in an article one of their staffers published on STAT.) NewsGuard is a browser extension that […]


NY Times “Well” column is unwell again – this time on pandemic running advice

I admire much of the great journalism being delivered by the New York Times on COVID-19 pandemic issues. But I continue to be befuddled many weeks by the decision-making and editorial judgment of the Times’ Well column.  We have written several times about how unwell is the Well feature. Today, one of our former physician-contributors, […]


Tips & Resources for Analyzing Health Care Claims

View More